Atlanta, Georgia (April 7, 2022) – A newly minted sponsor of the Southeast Life Sciences AdvanSE 2022 conference, Keiretsu Forum’s Mid-Atlantic and South-East regions have committed to providing pitch opportunities to both regions for the winners of the PitchRounds competition.
Each of the four (4) finalist pitch companies will be eligible for a Keiretsu workshop covering due diligence, term sheets, and valuation. The top two (2) companies will have the opportunity to pitch to Keiretsu’s Mid-Atlantic and South-East Regions.
AdvanSE is the Southeast’s premier, must-attend event for the biopharma, medtech, diagnostic, digital health, and ag tech industries wishing to do business in the Southeast region. It attracts the best of the southeast’s innovation, research, and people. The 2022 edition is May 25 – 27 in Alpharetta, Georgia.
Keiretsu Forum’s Mid-Atlantic and South-East is part of Keiretsu Forum, a global investment community of over 3,000 accredited private equity angel investors, venture capitalists, and corporate/ institutional investor members with 55 chapters on 4 continents. Since Keiretsu Forum’s founding in 2000, members have invested more than $1 billion in 950+ different companies. In 2021, Keiretsu Forum Mid-Atlantic and South-East regional members invested over $13.1 M in 45 companies breaking the group’s investing level record for the second year in a row.
“The Life Science silo is of significant importance to Keiretsu,” says Howard Lubert, Area President for Keiretsu Forum Mid-Atlantic and South-East. “As reported in Pitchbook 2021 Global Tables last month, Keiretsu Forum is #1 in the healthcare devices and supplies sector and #4 in the pharma and biotech sector. We see our sponsorship of Southeast Life Sciences AdvanSE 2022 conference as important to maintaining the exponential growth of the life science ecosystem for Founders and our funders.”
In the past 20 years, 501 PitchRounds presenting companies have raised $7.2 billion dollars. 70 companies subsequently executed M&A and IPO events and counting.
“We are grateful to Keiretsu Forum for the high value support these opportunities for PitchRounds at AdvanSE 2022 present to the finalists and winners,” said Ashley Hancock, the 2022 AdvanSE Chair, Southeast Life Sciences board member, and Founder of Innovetica. “Attracting high potential early and later stage innovative life science companies is paramount to our mission and of top interest to our attending investors. Keiretsu’s commitment to PitchRounds at AdvanSE 2022 will contribute significantly to our accomplishment of that mission.”
# # #
About Southeast Life Sciences
Southeast Life Sciences cultivates, convenes, and connects the Southeast entrepreneurial ecosystem to foster life science innovation in promising companies throughout the region from investors across the country. Investors count on the organization to present to them the highest potential life science investments the southeast United States has to offer.
About Keiretsu Forum Mid-Atlantic and South-East
Keiretsu Forum’s Mid-Atlantic and Southeast is part of Keiretsu Forum, a global investment community of accredited private equity angel investors, venture capitalists, and corporate/ institutional investors. Keiretsu Forum was founded in 2000 by Randy Williams in San Francisco. Today’s Keiretsu Forum is a worldwide network of capital, resources, and deal flow with 55 chapters on 4 continents. Keiretsu Forum members invest in high-quality, diverse investment opportunities. The community is strengthened through its involvement in social and charitable activities. To be a guest at an upcoming meeting, register here.